Previous close | 165.64 |
Open | 168.50 |
Bid | 160.50 x 0 |
Ask | 160.86 x 0 |
Day's range | 156.86 - 161.18 |
52-week range | 92.57 - 177.98 |
Volume | |
Avg. volume | 212 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 30 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Alphabet stock has gained about 15% this year — but even tech's winners face high expectations from investors this earnings season.
Walgreens is launching new services and consolidating specialty services to compete in the pharmacy benefits management (PBM) space.
Amazon.com Inc. (NASDAQ:AMZN) Founder Jeff Bezos has always been unusually frank about the potential decline and eventual demise of his company. This sentiment has been a recurring theme in his communications, expressing a clear understanding that even the mightiest companies have limited lifespans. Bezos has often used this perspective as a rallying cry to drive innovation at Amazon, pushing the company to stay ahead of potential decline through continuous evolution and reinvention. Under Bezos